To find out if TAVR is an option for you or someone you love, call our Valve Clinic at (843) 692-4710.
A New, Minimally Invasive Procedure
Grand Strand Medical Center is one of a small number of hospitals in South Carolina that offers the Transcatheter Aortic Valve Replacement (TAVR) procedure. TAVR can help patients with severe aortic stenosis feel better and live longer. It is the only valve replacement option for patients with severe aortic stenosis who are not well enough to undergo traditional surgery.
The TAVR Procedure
Transcatheter Aortic Valve Replacement, also known as TAVR, is a procedure that involves using a catheter to thread the replacement valve from a blood vessel in the leg to the heart’s diseased aortic valve and replace it with a new valve without requiring open heart surgery. The malfunctioning valve is opened with a balloon and the new valve is anchored in place, leaving patients with a smoothly operating valve that delivers better blood flow from the heart to the rest of the body. TAVR is a minimally in vasive procedure that does not require open heart surgery.
The benefits of TAVR, in patients who qualify, can include:
- Fewer days in the ICU and shorter hospital stays
- Earlier return to normal activities
- Less blood loss than with conventional open-heart surgery
What is TAVR?
Learn what transcatheter aortic valve replacement (TAVR) is from our heart care TAVR team of physicians. They will walk you through what TAVR is, the team approach, the ideal candidate and the recovery process.
Frequently Asked Questions About TAVR
Transcatheter Aortic Valve Replacement (TAVR) is performed on high risk patients with aortic stenosis (AS). All patients are carefully evaluated to see if they meet the TAVR guidelines. The goal is to provide the best treatment for each individual patient.
In November 2011, the U.S. Food and Drug Administration approved the SAPIEN Transcatheter Heart Valve for the treatment of patients with severe AS native aortic valve stenosis who have been determined by two cardiac surgeons to be high-risk for open aortic valve replacement, and in whom existing co-morbidities would not preclude the expected benefit from the correction of the aortic stenosis.
There are ongoing trials for TAVR for high risk operable, moderate risk operable and inoperable patients.
There are still risks as sociated with TAVR as there is with surgical AVR (Aortic Valve Repair). These should be taken into consideration when discussing this procedure with your cardiologist.